ENTERO HEALTHCARE SOLU L

Distributes pharmaceutical and healthcare products to a retail network of more than 105,300 pharmacies and 3,600 hospitals, supported by 136 warehouses, 137 offices and 48 subsidiaries spread across 21 states and 523 districts. In FY26, the business reported revenue of Rs 6,591 crore, up 29.3% year-on-year with 31.5% like-for-like growth, while EBITDA rose 55% to Rs 266 crore at a 4.0% margin. Growth has come from a mix of like-for-like expansion and acquisitions — seven acquisitions were completed during the year, including a 51.51% stake in Anand Chemiceutics. A MedTech line has scaled to annualized revenue exceeding Rs 1,000 crore, and the company employs about 4,970 staff. Stated operating cost items are employee costs at 3.7% of revenue, other operating expenses at 2.6% and depreciation at 0.7%, with capex at 1.0% of revenue. Operating cash flow turned positive at Rs 96 crore in FY26, although Q4 FY26 absorbed Rs 114 million in one-off items including business contract closure expenses and write-offs.